Neuro-reset: Implantable Electrochemical System for Amyloid Depolymerization

NEURO-RESET is a revolutionary implantable bioelectronic system designed for the physical depolymerization of amyloid-beta plaques, offering a non-enzymatic and non-antibody approach to treating Alzheimer’s Disease. The technology bypasses the blood-brain barrier (BBB) limitations that cause most pharmaceutical failures in neurodegeneration. The Technology: > The system consists of a miniaturized implantable pulse generator (28 x 42 x 12 mm) and a proprietary Pt-Ir electrode array. It delivers precisely calibrated electrochemical pulses that disrupt the hydrogen bonding and hydrophobic interactions holding amyloid aggregates together, effectively "melting" the plaques at a molecular level without damaging healthy neural tissue. Key Innovation: Physical Cleansing: Unlike Aducanumab or other drugs, NEURO-RESET does not rely on the immune system to clear plaques; it actively deconstructs them via controlled bio-electrical resonance. Real-Time Monitoring: Integrated impedance spectroscopy allows the device to adjust treatment intensity based on the local density of plaque deposits. Safe Integration: Encapsulated in a biocompatible Titanium housing, designed for a 10-year service life with wireless charging capabilities. Market Impact: > NEURO-RESET offers a one-time surgical solution for a disease that currently costs the global economy trillions in long-term care, shifting the paradigm from palliative treatment to active physiological restoration.